Overview A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions Status: Recruiting Trial end date: 2022-05-09 Target enrollment: Participant gender: Summary A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions Phase: Phase 1 Details Lead Sponsor: Chong Kun Dang Pharmaceutical